JP2022000650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022000650A5 JP2022000650A5 JP2021154089A JP2021154089A JP2022000650A5 JP 2022000650 A5 JP2022000650 A5 JP 2022000650A5 JP 2021154089 A JP2021154089 A JP 2021154089A JP 2021154089 A JP2021154089 A JP 2021154089A JP 2022000650 A5 JP2022000650 A5 JP 2022000650A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- kit
- mmp
- expression
- degree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000090 biomarker Substances 0.000 claims 28
- 238000000034 method Methods 0.000 claims 15
- 108010063738 Interleukins Proteins 0.000 claims 7
- 102000015696 Interleukins Human genes 0.000 claims 7
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 6
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 6
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims 6
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 6
- 102000003896 Myeloperoxidases Human genes 0.000 claims 6
- 108090000235 Myeloperoxidases Proteins 0.000 claims 6
- 208000019693 Lung disease Diseases 0.000 claims 5
- 108090001007 Interleukin-8 Proteins 0.000 claims 4
- 208000006673 asthma Diseases 0.000 claims 4
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 4
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 4
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 3
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 3
- 108090000174 Interleukin-10 Proteins 0.000 claims 3
- 108010065805 Interleukin-12 Proteins 0.000 claims 3
- 108090000978 Interleukin-4 Proteins 0.000 claims 3
- 108010002616 Interleukin-5 Proteins 0.000 claims 3
- 108010002586 Interleukin-7 Proteins 0.000 claims 3
- 102000016267 Leptin Human genes 0.000 claims 3
- 108010092277 Leptin Proteins 0.000 claims 3
- 102000007156 Resistin Human genes 0.000 claims 3
- 108010047909 Resistin Proteins 0.000 claims 3
- 102000054727 Serum Amyloid A Human genes 0.000 claims 3
- 108700028909 Serum Amyloid A Proteins 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 3
- 229940039781 leptin Drugs 0.000 claims 3
- 210000002540 macrophage Anatomy 0.000 claims 3
- 238000013508 migration Methods 0.000 claims 3
- 230000005012 migration Effects 0.000 claims 3
- 230000001483 mobilizing effect Effects 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 239000013060 biological fluid Substances 0.000 claims 1
- 238000012512 characterization method Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 230000005732 intercellular adhesion Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024003857A JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2025078265A JP2025114736A (ja) | 2009-03-12 | 2025-05-08 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/403,369 | 2009-03-12 | ||
| US12/403,369 US8541183B2 (en) | 2007-09-11 | 2009-03-12 | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| US23719809P | 2009-08-26 | 2009-08-26 | |
| US61/237,198 | 2009-08-26 | ||
| JP2019081332A JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019081332A Division JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024003857A Division JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022000650A JP2022000650A (ja) | 2022-01-04 |
| JP2022000650A5 true JP2022000650A5 (https=) | 2022-03-28 |
Family
ID=42729154
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554259A Pending JP2012520469A (ja) | 2009-03-12 | 2010-03-12 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2015151999A Active JP6250600B2 (ja) | 2009-03-12 | 2015-07-31 | 非小細胞肺癌バイオマーカーを検出する方法 |
| JP2017224257A Active JP6774925B2 (ja) | 2009-03-12 | 2017-11-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット |
| JP2019081332A Pending JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2021154089A Pending JP2022000650A (ja) | 2009-03-12 | 2021-09-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2024003857A Withdrawn JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2025078265A Pending JP2025114736A (ja) | 2009-03-12 | 2025-05-08 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554259A Pending JP2012520469A (ja) | 2009-03-12 | 2010-03-12 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2015151999A Active JP6250600B2 (ja) | 2009-03-12 | 2015-07-31 | 非小細胞肺癌バイオマーカーを検出する方法 |
| JP2017224257A Active JP6774925B2 (ja) | 2009-03-12 | 2017-11-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット |
| JP2019081332A Pending JP2019158890A (ja) | 2009-03-12 | 2019-04-22 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024003857A Withdrawn JP2024024128A (ja) | 2009-03-12 | 2024-01-15 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
| JP2025078265A Pending JP2025114736A (ja) | 2009-03-12 | 2025-05-08 | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11474104B2 (https=) |
| EP (4) | EP3444359A1 (https=) |
| JP (7) | JP2012520469A (https=) |
| KR (2) | KR102061441B1 (https=) |
| CN (4) | CN108181457B (https=) |
| AU (3) | AU2010223911A1 (https=) |
| CA (2) | CA2755301C (https=) |
| ES (1) | ES2703714T3 (https=) |
| PL (1) | PL3257953T3 (https=) |
| WO (1) | WO2010105235A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008117067A2 (en) | 2007-03-27 | 2008-10-02 | Carl Arne Krister Borrebaeck | Protein signature/markers for the detection of adenocarcinoma |
| AU2012249288C1 (en) * | 2011-04-29 | 2017-12-21 | Lung Cancer Proteomics Llc | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
| CN107923918A (zh) * | 2015-09-09 | 2018-04-17 | 私募蛋白质体公司 | 用于开发个性化药物治疗计划和基于蛋白质组谱的靶向药物开发的方法 |
| KR102087373B1 (ko) * | 2015-09-11 | 2020-03-10 | 주식회사 압타머사이언스 | 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법 |
| CN108473529B (zh) * | 2015-11-10 | 2023-04-18 | 伦斯勒中心转化研究公司 | 检测和治疗肺高压的方法 |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN112501140B (zh) * | 2020-12-16 | 2022-03-18 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽yfgsgfaapffivrhqllkk及其制备方法和应用 |
| TWI796010B (zh) * | 2021-11-23 | 2023-03-11 | 國立高雄大學 | 基質金屬蛋白酶-1胜肽拓印導電聚合物及其用途 |
| CN117907508A (zh) * | 2023-12-19 | 2024-04-19 | 查理高特(青岛)健康科技有限公司 | 基于代谢组学的高尿酸血症及尿酸性肾病的风险预测系统 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2280930C (en) | 1997-02-12 | 2010-04-06 | The Regents Of The University Of Michigan | Protein markers for lung cancer and use thereof |
| US20070092917A1 (en) | 1998-05-01 | 2007-04-26 | Isabelle Guyon | Biomarkers for screening, predicting, and monitoring prostate disease |
| EP1156823B1 (en) | 1999-02-12 | 2008-10-29 | The Scripps Research Institute | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| IL144559A0 (en) | 1999-03-01 | 2002-05-23 | Genentech Inc | Antibodies for cancer therapy and diagnosis |
| FI990888A0 (fi) * | 1999-04-20 | 1999-04-20 | Medix Biochemica Ab Oy | Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi |
| BR0010068A (pt) * | 1999-04-26 | 2002-12-17 | Surromed Inc | Sistema de identificação do marcador fenotìpico e biológico |
| WO2002004600A2 (en) * | 2000-07-12 | 2002-01-17 | Smithkline Beecham Corporation | Novel compounds |
| KR20030094281A (ko) * | 2001-03-12 | 2003-12-11 | 모노젠, 인크. | 세포에 기초한 질병상태의 검출 및 질병상태의 구별 |
| US20030190602A1 (en) | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| JP2004532640A (ja) | 2001-06-05 | 2004-10-28 | オークランド ユニサーヴィスィズ リミテッド | 肺機能および障害の評価のための方法および組成物 |
| US20030134339A1 (en) | 2002-01-14 | 2003-07-17 | Thomas Brown | Proteomics based method for toxicology testing |
| US20060088537A1 (en) | 2002-04-11 | 2006-04-27 | Terrett Jonathan A | Protein involved in cancer |
| JP2006509186A (ja) | 2002-05-10 | 2006-03-16 | イースタン バージニア メディカル スクール | 前立腺癌バイオマーカー |
| WO2003101283A2 (en) * | 2002-06-04 | 2003-12-11 | Incyte Corporation | Diagnostics markers for lung cancer |
| TW200413725A (en) | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| CN1854313B (zh) * | 2002-09-30 | 2010-10-20 | 肿瘤疗法科学股份有限公司 | 非小细胞肺癌的诊断方法 |
| WO2004073623A2 (en) * | 2003-02-14 | 2004-09-02 | Children's Hospital & Research Center At Oakland | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| JP2007537984A (ja) * | 2003-03-04 | 2007-12-27 | ワイス | 喘息または他のアレルギー性もしくは炎症性疾患の診断および治療のための組成物および方法 |
| CN101265254A (zh) * | 2003-03-27 | 2008-09-17 | 兰肯瑙医学研究所 | 新型ido抑制剂及其使用方法 |
| JP2005044330A (ja) | 2003-07-24 | 2005-02-17 | Univ Of California San Diego | 弱仮説生成装置及び方法、学習装置及び方法、検出装置及び方法、表情学習装置及び方法、表情認識装置及び方法、並びにロボット装置 |
| US7700573B2 (en) | 2004-03-23 | 2010-04-20 | Oncotherapy Science, Inc. | Method for diagnosing non-small lung cancer |
| US20090204334A1 (en) | 2004-03-30 | 2009-08-13 | Eastern Virginia Medical School | Lung cancer biomarkers |
| US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| EP1805513A4 (en) * | 2004-10-20 | 2009-06-10 | Onco Detectors International L | MIGRATION HEMMFAKTORIM SERUM AS TUMORMARKER FOR PROSTATE, BLADDER, BREAST, OVARIAL, KIDNEY AND LUNG CARCINOMA |
| WO2006045318A2 (en) * | 2004-10-27 | 2006-05-04 | Aarhus Universitet | Diagnosis and treatment of immune-related diseases |
| CA2589782A1 (en) | 2004-11-30 | 2006-06-08 | Veridex Llc | Lung cancer prognostics |
| CN1300580C (zh) | 2004-12-31 | 2007-02-14 | 中国人民解放军第306医院 | 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用 |
| GB0508863D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Peptide |
| WO2006124451A2 (en) * | 2005-05-11 | 2006-11-23 | Centocor, Inc. | Anti-il-13 antibodies, compositions, methods and uses |
| US20070099239A1 (en) | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| EP2311985A1 (en) * | 2005-07-27 | 2011-04-20 | Oncotherapy Science, Inc. | Sirna for treating esophageal cancer |
| NZ612578A (en) * | 2005-08-19 | 2014-11-28 | Abbvie Inc | Dual variable domain immunoglobin and uses thereof |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| JPWO2007026773A1 (ja) | 2005-08-31 | 2009-03-12 | 学校法人 久留米大学 | 医用診断処理装置 |
| US7955837B2 (en) | 2005-10-29 | 2011-06-07 | Bayer Technology Services Gmbh | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof |
| US9347945B2 (en) | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| KR100760518B1 (ko) | 2006-07-18 | 2007-09-20 | 삼성정밀공업 주식회사 | 가구용 도어의 닫힘 충격 완충 장치 |
| US7840505B2 (en) | 2006-11-02 | 2010-11-23 | George Mason Intellectual Properties, Inc. | Classification tool |
| EP2087140A2 (en) * | 2006-11-13 | 2009-08-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| US8343491B2 (en) * | 2006-12-18 | 2013-01-01 | The Johns Hopkins University | Anti-HIMF antibodies to treat lung diseases |
| JP5085927B2 (ja) | 2006-12-21 | 2012-11-28 | ウィンテックポリマー株式会社 | 難燃性樹脂組成物 |
| CA2678626A1 (en) * | 2007-02-28 | 2008-09-04 | Novimmune S.A. | Anti-ip-10 antibodies and methods of use thereof |
| JP2010523979A (ja) | 2007-04-05 | 2010-07-15 | オーレオン ラボラトリーズ， インコーポレイテッド | 医学的状態の処置、診断および予測のためのシステムおよび方法 |
| EP2515116A1 (en) | 2007-05-18 | 2012-10-24 | Duke University | Serum biomarkers for the early detection of lung cancer |
| EP2156187A4 (en) | 2007-06-15 | 2010-07-21 | Biosite Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND / OR FORECASTING EGG CANCER AND LUNG CANCER |
| US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| KR20160096213A (ko) | 2007-09-11 | 2016-08-12 | 캔서 프리벤션 앤 큐어, 리미티드 | 인간 폐조직 병변의 지표가 되는 인간 혈청 내 단백질의 동정 |
| US8541183B2 (en) * | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| JP5159242B2 (ja) | 2007-10-18 | 2013-03-06 | キヤノン株式会社 | 診断支援装置、診断支援装置の制御方法、およびそのプログラム |
| CN101896817A (zh) | 2007-12-10 | 2010-11-24 | 霍夫曼-拉罗奇有限公司 | 用于结直肠癌的标记物组 |
| MX340916B (es) | 2008-01-18 | 2016-07-29 | President And Fellows Of Harvard College * | Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales. |
| CN102037355A (zh) | 2008-03-04 | 2011-04-27 | 里奇诊断学股份有限公司 | 基于多重生物标记物板块诊断和监测抑郁症 |
| CN101587125B (zh) | 2008-05-21 | 2013-07-24 | 林标扬 | 高表达癌症标记物和低表达组织器官标记物组合试剂盒 |
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CN104198709A (zh) | 2008-09-09 | 2014-12-10 | 私募蛋白质体公司 | 肺癌生物标记及其用途 |
| CN101988059B (zh) | 2009-07-30 | 2014-04-02 | 江苏命码生物科技有限公司 | 胃癌检测标记物及其检测试剂盒和生物芯片 |
| KR20140024860A (ko) | 2011-02-24 | 2014-03-03 | 버밀리언, 인코포레이티드 | 난소암에 대한 바이오마커 패널，진단 방법 및 시험 키트 |
| AU2012249288C1 (en) | 2011-04-29 | 2017-12-21 | Lung Cancer Proteomics Llc | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| WO2015066564A1 (en) | 2013-10-31 | 2015-05-07 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| WO2015138769A1 (en) | 2014-03-12 | 2015-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for assessing patients with non-small cell lung cancer |
-
2010
- 2010-03-12 CN CN201810113758.4A patent/CN108181457B/zh active Active
- 2010-03-12 CA CA2755301A patent/CA2755301C/en active Active
- 2010-03-12 CN CN202110251315.3A patent/CN113189342B/zh active Active
- 2010-03-12 EP EP18194795.3A patent/EP3444359A1/en active Pending
- 2010-03-12 JP JP2011554259A patent/JP2012520469A/ja active Pending
- 2010-03-12 CA CA3024643A patent/CA3024643C/en active Active
- 2010-03-12 KR KR1020187026414A patent/KR102061441B1/ko active Active
- 2010-03-12 CN CN201410593458.2A patent/CN104535765A/zh active Pending
- 2010-03-12 EP EP10751519A patent/EP2406401A4/en not_active Withdrawn
- 2010-03-12 CN CN2010800172205A patent/CN102405296A/zh active Pending
- 2010-03-12 EP EP17179032.2A patent/EP3257953B1/en active Active
- 2010-03-12 AU AU2010223911A patent/AU2010223911A1/en not_active Abandoned
- 2010-03-12 ES ES17179032T patent/ES2703714T3/es active Active
- 2010-03-12 KR KR1020117023448A patent/KR101900016B1/ko active Active
- 2010-03-12 WO PCT/US2010/027243 patent/WO2010105235A2/en not_active Ceased
- 2010-03-12 PL PL17179032T patent/PL3257953T3/pl unknown
- 2010-03-12 EP EP14182060.5A patent/EP2857522A3/en not_active Withdrawn
-
2015
- 2015-07-31 JP JP2015151999A patent/JP6250600B2/ja active Active
-
2016
- 2016-09-14 AU AU2016228188A patent/AU2016228188B2/en active Active
-
2017
- 2017-11-22 JP JP2017224257A patent/JP6774925B2/ja active Active
-
2018
- 2018-03-23 AU AU2018202110A patent/AU2018202110B2/en active Active
- 2018-03-30 US US15/941,046 patent/US11474104B2/en active Active
-
2019
- 2019-04-22 JP JP2019081332A patent/JP2019158890A/ja active Pending
-
2021
- 2021-09-22 JP JP2021154089A patent/JP2022000650A/ja active Pending
-
2024
- 2024-01-15 JP JP2024003857A patent/JP2024024128A/ja not_active Withdrawn
-
2025
- 2025-05-08 JP JP2025078265A patent/JP2025114736A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022000650A5 (https=) | ||
| JP7603115B2 (ja) | 測定分析物を使用する、疾患診断を改善するための方法 | |
| CN105164535B (zh) | 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法 | |
| JP2024024128A (ja) | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット | |
| Dissanayake et al. | Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A | |
| De Sloovere et al. | Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease | |
| WO2014150198A2 (en) | Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof | |
| US10725039B2 (en) | Biomarker signatures for Lyme disease and methods of use thereof | |
| CN106461664A (zh) | 用于肺癌的循环肿瘤细胞诊断 | |
| CN105849566B (zh) | 肾脏疾病生物标志物 | |
| JP2016006426A5 (https=) | ||
| Heegaard et al. | Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival | |
| WO2019202448A1 (en) | A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis | |
| WO2015164616A1 (en) | Biomarkers for detection of tuberculosis | |
| US10725038B2 (en) | Biomarker signatures for lyme disease differentiation and methods of use thereof | |
| JP7547332B2 (ja) | 膀胱癌の検出 | |
| Bhalerao et al. | Microfluidic immunoarray for point-of-care detection of cytokines in COVID-19 patients | |
| CN114758719A (zh) | 一种结直肠癌预测系统及其应用 | |
| Wang et al. | Afamin expression in breast cancer | |
| CN114755422B (zh) | 一种结直肠癌检测的生物标志物及其应用 | |
| US20240402176A1 (en) | Detection of bladder cancer in males | |
| Kahveci et al. | Red cell distribution width-to-platelet count ratio is a promising predictor of functional bowel disease. | |
| Pokrovsky et al. | Multiplex analysis of ovarian cancer patients using glycan microarray | |
| EP2534491B1 (en) | Compositons and methods for predicting cardiovascular events | |
| CN114200138A (zh) | 用于诊断和分期结直肠癌的生物标记物 |